Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Effect of Intranasal Oxymetazoline Spray on Intraoperative Bleeding During Rhinoplasty
IRCT20260508069292N1Phase 3Recruiting
- Sponsor
- Isfahan University of Medical Sciences
- Start
- May 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3 trial of oxymetazoline in intraoperative bleeding, sponsored by Isfahan University of Medical Sciences. Started May 2026; status: recruiting.
02
Drugs
oxymetazoline
03
Conditions
intraoperative bleeding
Beyond the preview
Go deeper on IRCT20260508069292N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20260508069292N1.